CASC

Cascadian Therapeutics, Inc.
CASC

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

CASC was delisted on the 8th of March, 2018.

Back to rankings

66 hedge funds and large institutions have $44.3M invested in Cascadian Therapeutics, Inc. in 2013 Q2 according to their latest regulatory filings, with 66 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $
Holders
66
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.3M
Puts
$409K
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$12.6M
2
$3.31M
3
$3.22M
4
$3.06M
5
$2.41M
6
$2.11M
7
$2.02M
8
$1.97M
9
$1.49M
10
$1.27M
11
$1.03M
12
$874K
13
$851K
14
$779K
15
$687K
16
$630K
17
$569K
18
$477K
19
$413K
20
$410K
21
$384K
22
$358K
23
$329K
24
$314K
25
$290K
1
2 3